You searched for tofacitinib

DDW 2022

Tofacitinib, Vedolizumab Effective for UC Post-Anti-TNF Agent Failure

May 24, 2022

Researchers compared the effectiveness of tofacitinib and vedolizumab among patients with UC who had experienced anti-TNF failure.

News

DMARDs Not Linked to Alzheimer Risk for Seniors With RA

April 13, 2022

No reduction in ADRD risk seen for treatment with tofacitinib, tocilizumab, TNF inhibitors versus abatacept

News

CV, Cancer Risk Up With Tofacitinib for Rheumatoid Arthritis

January 31, 2022

Incidences of major adverse cardiovascular events, cancers higher with tofacitinib versus TNF inhibitor; criteria for noninferiority not met

News

WHO Living Guideline Updated for Drug Treatment of COVID-19

January 18, 2022

JAK inhibitor baricitinib strongly recommended for the treatment of severe or critical COVID-19

News

Xeljanz/Xeljanz XR Approved for Active Ankylosing Spondylitis

December 15, 2021

The approval was based on data from a phase 3 study which evaluated tofacitinib in adults with active AS who had an inadequate response to at least 2 NSAIDs.

News

Rinvoq Labeling Updated to Include Class Warnings Related to JAK Inhibitors

December 6, 2021

The update follows the FDA’s Drug Safety Communication, which was based on a completed review of a large randomized safety clinical trial evaluating tofacitinib in patients with rheumatoid arthritis.

Drugs in the Pipeline

AbbVie Seeks Approval of Upadacitinib for Ulcerative Colitis

September 16, 2021

The applications are supported by data from two 2two phase 3 induction studies and one 1 maintenance study.

Safety Alerts and Recalls

FDA: New Warnings and Limitations Set for Certain JAK Inhibitors

September 1, 2021

The revisions are based on a completed review of a large randomized safety clinical trial, which included 4362 patients with rheumatoid arthritis.

News

Recommendations Provided for Treatment of Ulcerative Colitis

March 5, 2020

Infliximab, adalimumab, golimumab, vedolizumab, tofacitinib, ustekinumab recommended over no tx

ACR 2019, News

Few Serious Infections in Offspring Exposed to Non-TNFi Biologics, Tofacitinib

November 11, 2019

Researchers compared the risk for serious infections in offspring of mothers with chronic inflammatory diseases who received non-TNFi biologics or tofacitinib during pregnancy vs offspring who were unexposed, but exposed to TNFi in utero.

Active Filters

Your search for tofacitinib returned 38 results

Sort Results:

Tofacitinib, Vedolizumab Effective for UC Post-Anti-TNF Agent Failure

DMARDs Not Linked to Alzheimer Risk for Seniors With RA

CV, Cancer Risk Up With Tofacitinib for Rheumatoid Arthritis

WHO Living Guideline Updated for Drug Treatment of COVID-19

Xeljanz/Xeljanz XR Approved for Active Ankylosing Spondylitis

Rinvoq Labeling Updated to Include Class Warnings Related to JAK Inhibitors

AbbVie Seeks Approval of Upadacitinib for Ulcerative Colitis

FDA: New Warnings and Limitations Set for Certain JAK Inhibitors

Recommendations Provided for Treatment of Ulcerative Colitis

Few Serious Infections in Offspring Exposed to Non-TNFi Biologics, Tofacitinib